About: covid:PMC6100582

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC6100582 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Schols, Dominique Beus, Maja Rajić, Zrinka Zorc, Branka Persoons, Leentje Jampílek, Josef Keser, Toma Kosalec, Ivan Michnová, Hana Vlainić, Josipa Szostak, Michal
is schema:about of	named entity 'ACCEPTORS' named entity 'ASYMMETRIC' named entity 'MICHAEL' named entity 'PRIMAQUINE' named entity 'NOVEL' named entity 'ACTIVE' named entity 'BIOLOGICALLY' named entity 'zanamivir' named entity 'Chemicalize.org' named entity 'Staphylococci' named entity '8.3' named entity 'cytotoxicity' named entity 'm/z' named entity 'biofilm' named entity 'atom' named entity '3.03' named entity 'S. marcescens' named entity 'acute myeloid leukemia' named entity 'methanol' named entity '3.10' named entity 'MS/MS' named entity '3.20' named entity 'cytostatic' named entity 'BioMérieux' named entity 'IC50' named entity 'prodrug' named entity 'cell cultures' named entity 'mycophenolic acid' named entity 'PBS' named entity 'cyclohexane' named entity 'vaccinia virus' named entity '1H NMR' named entity 'C. albicans' named entity 'HSV-1' named entity 'M. smegmatis' named entity 'DMSO-d6' named entity 'GSH' named entity 'MS/MS' named entity 'disulfide bond formation' named entity 'ingenol mebutate' named entity 'parafilm' named entity 'm/z' named entity 'tetrazolium chloride' named entity 'primary amino group' named entity 'dextran' named entity 'multiple myeloma' named entity 'Antiviral activity' named entity 'glucose' named entity 'H-bond' named entity 'Michael acceptors' named entity 'dione' named entity 'Molecular ion' named entity 'nephelometer' named entity 'Hela cell' named entity 'NCI-H460' named entity 'mobile phase' named entity 'ether' named entity 'silica gel' named entity 'Michael acceptors' named entity 'assay' named entity 'positive controls' named entity 'tripeptide' named entity 'amino group' named entity 'mmol' named entity 'conjugated' named entity 'vancomycin' named entity 'crystal violet' named entity 'Riga' named entity 'P. mirabilis' named entity 'α,β-unsaturated carbonyl' named entity 'HL-60' named entity 'canertinib' named entity 'ether' named entity 'C. krusei' named entity 'phenyl' named entity '10.11' named entity 'actinic keratosis' named entity 'IC50' named entity 'cidofovir' named entity 'clinical trials' named entity 'm/z' named entity 'drug candidate' named entity 'mmol' named entity 'mmol' named entity 'mobile phase' named entity 'C. krusei' named entity 'erythroleukemia' named entity 'supernatant' named entity 'mobile phase'

Attributes

Values

Creator

Schols, Dominique
Beus, Maja
Rajić, Zrinka
Zorc, Branka
Persoons, Leentje
Jampílek, Josef
Keser, Toma
Kosalec, Ivan
Michnová, Hana
Vlainić, Josipa
Szostak, Michal

is schema:about of

named entity 'ACCEPTORS'
named entity 'ASYMMETRIC'
named entity 'MICHAEL'
named entity 'PRIMAQUINE'
named entity 'NOVEL'
named entity 'ACTIVE'
named entity 'BIOLOGICALLY'
named entity 'zanamivir'
named entity 'Chemicalize.org'
named entity 'Staphylococci'
named entity '8.3'
named entity 'cytotoxicity'
named entity 'm/z'
named entity 'biofilm'
named entity 'atom'
named entity '3.03'
named entity 'S. marcescens'
named entity 'acute myeloid leukemia'
named entity 'methanol'
named entity '3.10'
named entity 'MS/MS'
named entity '3.20'
named entity 'cytostatic'
named entity 'BioMérieux'
named entity 'IC50'
named entity 'prodrug'
named entity 'cell cultures'
named entity 'mycophenolic acid'
named entity 'PBS'
named entity 'cyclohexane'
named entity 'vaccinia virus'
named entity '1H NMR'
named entity 'C. albicans'
named entity 'HSV-1'
named entity 'M. smegmatis'
named entity 'DMSO-d6'
named entity 'GSH'
named entity 'MS/MS'
named entity 'disulfide bond formation'
named entity 'ingenol mebutate'
named entity 'parafilm'
named entity 'm/z'
named entity 'tetrazolium chloride'
named entity 'primary amino group'
named entity 'dextran'
named entity 'multiple myeloma'
named entity 'Antiviral activity'
named entity 'glucose'
named entity 'H-bond'
named entity 'Michael acceptors'
named entity 'dione'
named entity 'Molecular ion'
named entity 'nephelometer'
named entity 'Hela cell'
named entity 'NCI-H460'
named entity 'mobile phase'
named entity 'ether'
named entity 'silica gel'
named entity 'Michael acceptors'
named entity 'assay'
named entity 'positive controls'
named entity 'tripeptide'
named entity 'amino group'
named entity 'mmol'
named entity 'conjugated'
named entity 'vancomycin'
named entity 'crystal violet'
named entity 'Riga'
named entity 'P. mirabilis'
named entity 'α,β-unsaturated carbonyl'
named entity 'HL-60'
named entity 'canertinib'
named entity 'ether'
named entity 'C. krusei'
named entity 'phenyl'
named entity '10.11'
named entity 'actinic keratosis'
named entity 'IC50'
named entity 'cidofovir'
named entity 'clinical trials'
named entity 'm/z'
named entity 'drug candidate'
named entity 'mmol'
named entity 'mmol'
named entity 'mobile phase'
named entity 'C. krusei'
named entity 'erythroleukemia'
named entity 'supernatant'
named entity 'mobile phase'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software